JPMorgan Retains Neutral Stance on Enact (ACT) Despite Minor Target Trim

Core Insights - Enact Holdings, Inc. (NASDAQ:ACT) is recognized as one of the 14 best up-and-coming dividend stocks to buy [1] - JPMorgan has maintained a neutral stance on Enact, reducing its price target from $40 to $39 following the company's Q3 update [2] Financial Performance - For Q3 2025, Enact reported total revenue of $311.4 million, a slight increase from $309.5 million year-over-year [3] - Premiums for the quarter were $244.6 million, down from $249 million in the same period last year [3] - The company held $339 million in cash and cash equivalents and $311 million in invested assets as of September 30, indicating stability in financial position [3] Insurance Metrics - New insurance written reached $14 billion for the quarter, reflecting a 6% increase from Q2 2025 and a 3% increase from Q3 2024 [4] - Monthly premium policies constituted 97% of the new insurance volume, while purchase originations accounted for 93% [4] - Primary insurance in force rose to $272 billion, compared to $270 billion in the previous quarter and $268 billion a year ago [4] Shareholder Returns - Enact emphasized its commitment to shareholder returns, distributing $31 million in dividends during the quarter [4] - The company continues to support lenders by backing mortgage loans, facilitating access to homeownership for more borrowers [5]